SuperGen, Inc. to Announce 2007 Third Quarter Financial Results October 29, 2007

DUBLIN, Calif., Oct. 22 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2007 third quarter financial results on Monday, Oct. 29, 2007. SuperGen Management will provide details on the Company's 2007 third quarter financial results, and any revised outlook for the future.

A press release will be transmitted to the news media immediately following the close of the market on Oct. 29. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast is accessible via the investor relations section of the Company's Web site at www.supergen.com. A webcast replay of the live conference call will be available for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

mary.vegh@supergen.comtenns@supergen.com

CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & Business
Development, +1-925-560-0100, ext. 111, tenns@supergen.com, or Mary M.
Vegh, Manager, Investor Relations, +1-925-560-2845, mary.vegh@supergen.com,
both of SuperGen Inc.

Web site: http://www.supergen.com/